Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alexandra Calmy

Showing results (371-380 of 415) with videos related to

Pageof 42
Sort By:
Pharmaceutics|August 26, 2022
Real-Life Therapeutic Concentration Monitoring of Long-Acting Cabotegravir and Rilpivirine: Preliminary Results of an Ongoing Prospective Observational Study in SwitzerlandPaul Thoueille, Susana Alves Saldanha, Fabian Schaller, et al.
Journal of the International AIDS Society|July 26, 2018
Expert consensus statement on the science of HIV in the context of criminal lawFrançoise Barré-Sinoussi, Salim S Abdool Karim, Jan Albert, et al.
PLOS Global Public Health|February 14, 2025
International healthcare workers' experiences and perceptions of the 2022 multi-country mpox outbreakVanessa Apea, Boghuma K Titanji, Francesca H Dakin, et al.
Nature Communications|November 3, 2020
Heritability of the HIV-1 reservoir size and decay under long-term suppressive ARTChenjie Wan, Nadine Bachmann, Venelin Mitov, et al.
Nature Medicine|September 2, 2024
Sustained HIV remission after allogeneic hematopoietic stem cell transplantation with wild-type CCR5 donor cellsAsier Sáez-Cirión, Anne-Claire Mamez, Véronique Avettand-Fenoel, et al.
The Lancet. HIV|December 4, 2018
Risks and benefits of dolutegravir-based antiretroviral drug regimens in sub-Saharan Africa: a modelling studyAndrew N Phillips, Francois Venter, Diane Havlir, et al.
The Journal of Antimicrobial Chemotherapy|February 4, 2023
Frequency matters: comparison of drug resistance mutation detection by Sanger and next-generation sequencing in HIV-1Suraj Balakrishna, Tom Loosli, Maryam Zaheri, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|January 3, 2025
Clinical Characterization and Outcomes of Human Clade IIb Mpox Virus Disease: A European Multicenter Mpox Observational Cohort Study (MOSAIC)Elise Pesonel, Cédric Laouénan, Laetitia Guiraud, et al.
Swiss Medical Weekly|June 27, 2022
Changes in mental and sexual health among MSM using HIV pre-exposure prophylaxis during the SARS-CoV-2 pandemic: longitudinal analysis of the SwissPrEPared cohort studyBabette L Winter, Frédérique Hovaguimian, Roger D Kouyos, et al.
Journal of Clinical Microbiology|May 20, 2016
Standard Genotyping Overestimates Transmission of Mycobacterium tuberculosis among Immigrants in a Low-Incidence CountryDavid Stucki, Marie Ballif, Matthias Egger, et al.
Pageof 42

Showing results (371-380 of 415) with videos related to

Sort By:
Pageof 42
Pharmaceutics|August 26, 2022
Real-Life Therapeutic Concentration Monitoring of Long-Acting Cabotegravir and Rilpivirine: Preliminary Results of an Ongoing Prospective Observational Study in SwitzerlandPaul Thoueille, Susana Alves Saldanha, Fabian Schaller, et al.
Journal of the International AIDS Society|July 26, 2018
Expert consensus statement on the science of HIV in the context of criminal lawFrançoise Barré-Sinoussi, Salim S Abdool Karim, Jan Albert, et al.
PLOS Global Public Health|February 14, 2025
International healthcare workers' experiences and perceptions of the 2022 multi-country mpox outbreakVanessa Apea, Boghuma K Titanji, Francesca H Dakin, et al.
Nature Communications|November 3, 2020
Heritability of the HIV-1 reservoir size and decay under long-term suppressive ARTChenjie Wan, Nadine Bachmann, Venelin Mitov, et al.
Nature Medicine|September 2, 2024
Sustained HIV remission after allogeneic hematopoietic stem cell transplantation with wild-type CCR5 donor cellsAsier Sáez-Cirión, Anne-Claire Mamez, Véronique Avettand-Fenoel, et al.
The Lancet. HIV|December 4, 2018
Risks and benefits of dolutegravir-based antiretroviral drug regimens in sub-Saharan Africa: a modelling studyAndrew N Phillips, Francois Venter, Diane Havlir, et al.
The Journal of Antimicrobial Chemotherapy|February 4, 2023
Frequency matters: comparison of drug resistance mutation detection by Sanger and next-generation sequencing in HIV-1Suraj Balakrishna, Tom Loosli, Maryam Zaheri, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|January 3, 2025
Clinical Characterization and Outcomes of Human Clade IIb Mpox Virus Disease: A European Multicenter Mpox Observational Cohort Study (MOSAIC)Elise Pesonel, Cédric Laouénan, Laetitia Guiraud, et al.
Swiss Medical Weekly|June 27, 2022
Changes in mental and sexual health among MSM using HIV pre-exposure prophylaxis during the SARS-CoV-2 pandemic: longitudinal analysis of the SwissPrEPared cohort studyBabette L Winter, Frédérique Hovaguimian, Roger D Kouyos, et al.
Journal of Clinical Microbiology|May 20, 2016
Standard Genotyping Overestimates Transmission of Mycobacterium tuberculosis among Immigrants in a Low-Incidence CountryDavid Stucki, Marie Ballif, Matthias Egger, et al.
Pageof 42